Literature DB >> 19669312

Metabolic profiles in patients with chronic hepatitis C: a case-control study.

Ching-Sheng Hsu1, Chun-Jen Liu, Chen-Hua Liu, Chi-Ling Chen, Ming-Yang Lai, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao.   

Abstract

BACKGROUND: The clinical implications of metabolic profiles in patients with chronic hepatitis C remain controversial. To study the association of metabolic abnormalities with chronic hepatitis C, we conducted a case-control study with special emphasis on serum lipid pattern, fasting blood glucose, and adiponectin.
METHODS: We enrolled 500 patients with chronic hepatitis C and 536 sex and age-matched controls. Unadjusted and adjusted associations of demographic and metabolic variables were estimated.
RESULTS: Chronic hepatitis C patients had higher alanine aminotransferase (ALT) and high-density lipoprotein-cholesterol levels, but lower total cholesterol (TC), triglyceride (TG), and low-density lipoprotein-cholesterol levels than controls. Stratifying ALT level according to its upper limit of normal, HCV infection was associated with younger age, female gender, and higher TC levels in chronic hepatitis C patients with normal ALT levels, but with lower TC and lower TG levels in those with abnormal ALT levels. By using multiple linear regression analyses for subjects with available adiponectin data, presence of HCV infection was independently associated with higher serum adiponectin levels.
CONCLUSIONS: Metabolic profiles of chronic hepatitis C patients are affected by age, gender, serum adiponectin, and ALT levels. Further longitudinal studies are needed to clarify the complex interplay between HCV infection and metabolic profiles.

Entities:  

Year:  2008        PMID: 19669312      PMCID: PMC2716846          DOI: 10.1007/s12072-008-9064-3

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  44 in total

1.  Diagnosis, management, and treatment of hepatitis C.

Authors:  Doris B Strader; Teresa Wright; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2004-04       Impact factor: 17.425

2.  Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C.

Authors:  Chun-Jen Liu; Pei-Jer Chen; Yung-Ming Jeng; Wen-Ling Huang; Wei-Shiung Yang; Ming-Yang Lai; Jia-Horng Kao; Ding-Shinn Chen
Journal:  J Hepatol       Date:  2005-08       Impact factor: 25.083

3.  Interaction of hepatitis C virus core protein with retinoid X receptor alpha modulates its transcriptional activity.

Authors:  Takeya Tsutsumi; Tetsuro Suzuki; Takashi Shimoike; Ryosuke Suzuki; Kyoji Moriya; Yoshizumi Shintani; Hajime Fujie; Yoshiharu Matsuura; Kazuhiko Koike; Tatsuo Miyamura
Journal:  Hepatology       Date:  2002-04       Impact factor: 17.425

4.  Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection.

Authors:  S Caronia; K Taylor; L Pagliaro; C Carr; U Palazzo; J Petrik; S O'Rahilly; S Shore; B D Tom; G J Alexander
Journal:  Hepatology       Date:  1999-10       Impact factor: 17.425

5.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

6.  Hepatitis C virus infection in Taiwan.

Authors:  D S Chen; J T Wang; P J Chen; T H Wang; J L Sung
Journal:  Gastroenterol Jpn       Date:  1991-07

7.  Viral and metabolic factors influencing alanine aminotransferase activity in patients with chronic hepatitis C.

Authors:  Daniele Prati; Mitchell L Shiffman; Moisés Diago; Edward Gane; K Rajender Reddy; Paul Pockros; Patrizia Farci; Christopher B O'Brien; Pilar Lardelli; Steven Blotner; Stefan Zeuzem
Journal:  J Hepatol       Date:  2006-01-25       Impact factor: 25.083

8.  Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

Authors:  Jason M Hui; Alex Hodge; Geoffrey C Farrell; James G Kench; Adamandia Kriketos; Jacob George
Journal:  Hepatology       Date:  2004-07       Impact factor: 17.425

9.  Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.

Authors:  Jean Michel Petit; Muriel Benichou; Laurence Duvillard; Valerie Jooste; Jean Baptiste Bour; Anne Minello; Bruno Verges; Jean Marcel Brun; Philippe Gambert; Patrick Hillon
Journal:  Am J Gastroenterol       Date:  2003-05       Impact factor: 10.864

Review 10.  Potential cellular receptors involved in hepatitis C virus entry into cells.

Authors:  Daniel Favre; Beat Muellhaupt
Journal:  Lipids Health Dis       Date:  2005-04-19       Impact factor: 3.876

View more
  9 in total

1.  Hepatitis C virus and lipid profiles: more questions than answers?

Authors:  Ching-Sheng Hsu; Jia-Horng Kao
Journal:  Hepatol Int       Date:  2011-07-29       Impact factor: 6.047

2.  Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients.

Authors:  Ching-Sheng Hsu; Shih-Jer Hsu; Hung-Chia Chen; Chen-Hua Liu; Jenher Jeng; Chun-Jen Liu; Pei-Jer Chen; Ding-Shinn Chen; Jia-Horng Kao
Journal:  Hepatol Int       Date:  2012-07-08       Impact factor: 6.047

3.  Decreases in the serum VLDL-TG/non-VLDL-TG ratio from early stages of chronic hepatitis C: alterations in TG-rich lipoprotein levels.

Authors:  Motoi Nishimura; Haruna Yamamoto; Toshihiko Yoshida; Masanori Seimiya; Yuji Sawabe; Kazuyuki Matsushita; Hiroshi Umemura; Kazuyuki Sogawa; Hirotaka Takizawa; Osamu Yokosuka; Fumio Nomura
Journal:  PLoS One       Date:  2011-02-25       Impact factor: 3.240

4.  Lipid profile in cirrhotic patients and its relation to clinical outcome.

Authors:  Laura Boemeke; Lilian Bassani; Cláudio Augusto Marroni; Catarina Bertaso Andreatta Gottschall
Journal:  Arq Bras Cir Dig       Date:  2015 Apr-Jun

5.  Association between phase angle, anthropometric measurements, and lipid profile in HCV-infected patients.

Authors:  Mariana de Souza Dorna; Nara Aline Costa; Erick Prado de Oliveira; Ligia Yukie Sassaki; Fernando Gomes Romeiro; Sergio Alberto Rupp de Paiva; Marcos Ferreira Minicucci; Giovanni Faria Silva
Journal:  Clinics (Sao Paulo)       Date:  2013-12       Impact factor: 2.365

6.  Association between hepatitis B virus infection and metabolic syndrome: a retrospective cohort study in Shanghai, China.

Authors:  Yanbing Zhou; Yan Cui; Haiju Deng; Jinming Yu
Journal:  BMC Public Health       Date:  2014-05-28       Impact factor: 3.295

7.  Impact of Chronic Hepatitis C Virus Genotype 1b Infection on Triglyceride Concentration in Serum Lipoprotein Fractions.

Authors:  Tomohisa Nagano; Nobuyoshi Seki; Yoichi Tomita; Tomonori Sugita; Yuta Aida; Munenori Itagaki; Satoshi Sutoh; Hiroshi Abe; Akihito Tsubota; Yoshio Aizawa
Journal:  Int J Mol Sci       Date:  2015-08-31       Impact factor: 5.923

8.  Association of SCARB1 Gene Polymorphisms with Virological Response in Chronic Hepatitis C Patients Receiving Pegylated Interferon plus Ribavirin Therapy.

Authors:  Ching-Sheng Hsu; Shih-Jer Hsu; Wei-Liang Liu; Ding-Shinn Chen; Jia-Horng Kao
Journal:  Sci Rep       Date:  2016-08-26       Impact factor: 4.379

Review 9.  Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era.

Authors:  Heather L Stevenson; Netanya S Utay
Journal:  Trop Dis Travel Med Vaccines       Date:  2016-09-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.